Analyst Activity

RSS feed for this section
This category contains 35 posts

Recent Analyst Activity

By Trevor Sherwood ⋅ September 24, 2011 ⋅ Post a comment

Amarin (AMRN) 9/22 – Jefferies maintains buy, price target $25.00 9/22 – Wedbush maintains outperform, price target $18.00 Affymax (AFFY) 9/21 – Piper Jaffray maintains overweight, price target $10.00 9/19 – McNicoll Lewis & Vlak maintains buy, price target $12.00 Optimer (OPTR) 9/23 – Breann Murray Carret & Co maintains buy, price target $20.00 9/23 [...]

Recent Analyst Activity

By Trevor Sherwood ⋅ September 9, 2011 ⋅ Post a comment

Affymax (AFFY) 9/6 – Piper Jaffray maintains overweight, price target $10.00 Amarin (AMRN) 9/7 – Morgan Joseph maintains buy, price target $25.00 9/1 – Jefferies maintains buy, price target $25.00 9/1 – Canaccord Genuity maintains buy, price target $35.00 Ariad (ARIA) 9/7 – BMO Capital Markets initiates outperform, $18.00 Exelixis (EXEL) 9/9 – Stifel Nicolaus [...]

Recent Analyst Activity

By Trevor Sherwood ⋅ August 13, 2011 ⋅ Post a comment

Affymax (AFFY) 8/12 – Stifel Nicolaus maintains hold 8/11 – EVA Dimensions downgrade to hold with no price target (from buy, price target $15.00) 8/11 – McNicoll Lewis & Vlak maintains buy, price target $12.00 8/10 – Piper Jaffray maintains overweight, price target $10.00 8/9 – Robert W. Baird & Co. maintains outperform, price target [...]

Recent Analyst Activity

By Trevor Sherwood ⋅ July 30, 2011 ⋅ Post a comment

Affymax (AFFY) 7/27 – Lazard Capital Markets maintains buy, price target $13.00 7/27 – EVA Dimensions upgrades to buy from hold 7/27 – McNicoll Lewis & Vlak maintains buy, price target $12.00 Ariad (ARIA) 7/28 – Argus Research Corp maintains hold 7/26 – Cowen and Company maintains outperform BioSante (BPAX) 7/26 – McNicoll Lewis & [...]

«Previous —